SKP2 and cancer: Using publicly available TCGA (The Cancer Genome Atlas) data [31], we show that SKP2 copy number losses (i.e., shallow deletions) are frequent in many common cancer types and correspond with reduced mRNA expression and worse progression-free survival in CRC patients.